✦ LIBER ✦

S03 Alendronate prevents vertebral and clinical fractures in women with existing vertebral fractures: Results of the fracture intervention trial

✍ Scribed by DB Karpf; SR Cummings; DM Black; D Thompson

Book ID: 117532931
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 280 KB
Volume: 27
Category: Article
ISSN: 0378-5122
DOI: 10.1016/s0378-5122(97)80906-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of alendronate on rates of ve

The effect of alendronate on rates of vertebral and non-vertebral fractures in women with vertebral fractures: Preliminary results of the fracture intervention trial

✍ D M Black; S R Cummings; D Thompson; FIT Research Group 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 158 KB

Randomised trial of effect of alendronat

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

✍ Dennis M Black; Steven R Cummings; David B Karpf; Jane A Cauley; Desmond E Thomp 📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 57 KB

Change in Bone Turnover and Hip, Non-Spi

Change in Bone Turnover and Hip, Non-Spine, and Vertebral Fracture in Alendronate-Treated Women: The Fracture Intervention Trial

✍ Douglas C Bauer; Dennis M Black; Patrick Garnero; Marc Hochberg; Susan Ott; John 📂 Article 📅 2004 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 148 KB

Efficacy of continued alendronate for fr

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial

✍ Ann V Schwartz; Douglas C Bauer; Steven R Cummings; Jane A Cauley; Kristine E En 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 102 KB

## Abstract In the Fracture Intervention Trial (FIT) Long Term Extension (FLEX) Trial, 10 years of alendronate (ALN) did not significantly reduce the risk of nonvertebral fractures (NVFs) compared with 5 years of ALN. Continuing ALN reduced the risk of clinical but not morphometric vertebral fractu

Number and severity of prevalent vertebr

Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial

✍ Hiroshi Hagino, Masataka Shiraki, Masao Fukunaga… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 293 KB

Pharmacological interventions for the pr

Pharmacological interventions for the prevention of vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: does site-specificity exist?

✍ J.E Compston 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 55 KB